Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05604131 · ClinicalTrials.gov registry record · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
A Phase 2 study of Acute Myocardial Infarction Type 1, sponsored by Rohan Dharmakumar.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 89
- Enrollment target
- 1
- Study location
NCT05604131 is a Phase 2 study of Acute Myocardial Infarction Type 1 that is actively recruiting participants, run by Rohan Dharmakumar. The registered enrollment target is 89 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05604131, a Phase 2 study of Acute Myocardial Infarction Type 1, is actively recruiting participants, sponsored by Rohan Dharmakumar.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 89 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this randomized, controlled pilot study is to determine the efficacy of Deferiprone to reduce the amount of free iron inside the hemorrhagic zone of myocardial infarction among hemorrhagic myocardial infarction patients.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Deferiprone Tablets
Study Locations (1)
Indiana
- IU Methodist Hospital (IUHealth) - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2022-11-08 |
| Est. Completion | 2029-08-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05604131
The ClinicalTrials.gov registry entry for NCT05604131 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rohan Dharmakumar, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Myocardial Infarction Type 1 appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05604131 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT05604131 about?
NCT05604131 is a clinical study titled "Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients". The objective of this randomized, controlled pilot study is to determine the efficacy of Deferiprone to reduce the amount of free iron inside the hemorrhagic zone of myocardial infarction among hemorrhagic myocardial infarction patients.
What is the current status of trial NCT05604131?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 89 participants. The study started on 2022-11-08. Estimated completion is 2029-08-31.
What conditions does trial NCT05604131 study?
This clinical trial studies the following conditions: Acute Myocardial Infarction Type 1.
What interventions are being tested in trial NCT05604131?
The interventions under investigation include: Placebo (DRUG), Deferiprone Tablets (DRUG).
Who is sponsoring clinical trial NCT05604131?
This trial is sponsored by Rohan Dharmakumar, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05604131 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.